NIH funds antibiotic trial for HIV and emphysema | Cornell Chronicle
Weill Cornell Medicine received a five-year, $7.8 million grant from the National Heart, Lung, and Blood Institute, part of the National Institutes of Health, to study whether the antibiotic doxycycline can slow the progression of Chronic lung disease emphysema in people living with well-controlled HIV. “There are no treatments available to treat the progression of …
NIH funds antibiotic trial for HIV and emphysema | Cornell Chronicle Read More »
